96 related articles for article (PubMed ID: 26376140)
1. Out, Out--Making Amyloid's Candle Briefer.
Comenzo RL
N Engl J Med; 2015 Sep; 373(12):1167-9. PubMed ID: 26376140
[No Abstract] [Full Text] [Related]
2. Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.
Richards DB; Cookson LM; Berges AC; Barton SV; Lane T; Ritter JM; Fontana M; Moon JC; Pinzani M; Gillmore JD; Hawkins PN; Pepys MB
N Engl J Med; 2015 Sep; 373(12):1106-14. PubMed ID: 26176329
[TBL] [Abstract][Full Text] [Related]
3. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
Pepys MB; Herbert J; Hutchinson WL; Tennent GA; Lachmann HJ; Gallimore JR; Lovat LB; Bartfai T; Alanine A; Hertel C; Hoffmann T; Jakob-Roetne R; Norcross RD; Kemp JA; Yamamura K; Suzuki M; Taylor GW; Murray S; Thompson D; Purvis A; Kolstoe S; Wood SP; Hawkins PN
Nature; 2002 May; 417(6886):254-9. PubMed ID: 12015594
[TBL] [Abstract][Full Text] [Related]
4. [At last new light for the treatment of amyloidosis].
Pettersson T
Duodecim; 2003; 119(12):1097-8. PubMed ID: 12868354
[No Abstract] [Full Text] [Related]
5. Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.
Kolstoe SE; Ridha BH; Bellotti V; Wang N; Robinson CV; Crutch SJ; Keir G; Kukkastenvehmas R; Gallimore JR; Hutchinson WL; Hawkins PN; Wood SP; Rossor MN; Pepys MB
Proc Natl Acad Sci U S A; 2009 May; 106(18):7619-23. PubMed ID: 19372378
[TBL] [Abstract][Full Text] [Related]
6. [Novel therapeutic approach to amyloidosis: no implications as yet for patients with Alzheimer's disease].
Lemstra AW; Eikelenboom P; Meijer EW; van Gool WA
Ned Tijdschr Geneeskd; 2002 Sep; 146(37):1720-3. PubMed ID: 12357871
[TBL] [Abstract][Full Text] [Related]
7. Targeted treatment for amyloidosis.
Pepys-Vered ME; Pepys MB
Isr Med Assoc J; 2014 May; 16(5):277-80. PubMed ID: 24979830
[No Abstract] [Full Text] [Related]
8. Immunoradiometric assay for human serum amyloid P component.
Millar DJ; Hutchinson WL; Pepys MB
J Immunol Methods; 2011 Aug; 371(1-2):18-24. PubMed ID: 21708157
[TBL] [Abstract][Full Text] [Related]
9. Amyloid diseases: small drugs lead the attack.
Iversen L
Nature; 2002 May; 417(6886):231-3. PubMed ID: 12015581
[No Abstract] [Full Text] [Related]
10. Drug targets for amyloidosis.
Kolstoe SE; Wood SP
Biochem Soc Trans; 2010 Apr; 38(2):466-70. PubMed ID: 20298204
[TBL] [Abstract][Full Text] [Related]
11. Early role of iron in modulating amyloid's association with neurodegeneration.
Bilgel M; Bischof GN
Neurology; 2020 Nov; 95(18):809-810. PubMed ID: 32938784
[No Abstract] [Full Text] [Related]
12. Immunotherapeutic clearance of systemic amyloid deposits by antibodies to serum amyloid P component.
Pepys MB
Amyloid; 2017 Mar; 24(sup1):5-6. PubMed ID: 28019722
[No Abstract] [Full Text] [Related]
13. Amyloidosis: a clinico-pathophysiological synopsis.
Hirschfield GM
Semin Cell Dev Biol; 2004 Feb; 15(1):39-44. PubMed ID: 15036205
[TBL] [Abstract][Full Text] [Related]
14. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab.
Elkayam O; Hawkins PN; Lachmann H; Yaron M; Caspi D
Arthritis Rheum; 2002 Oct; 46(10):2571-3. PubMed ID: 12384913
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic amyloidosis].
Dao T; Davy A; Verwaerde JC; Galateau F; Valla A
Gastroenterol Clin Biol; 1990; 14(6-7):534-43. PubMed ID: 2397862
[No Abstract] [Full Text] [Related]
16. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist.
Grehan S; Herbert J; Whitehead AS
Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615
[TBL] [Abstract][Full Text] [Related]
17. [New trends in the treatment of amyloidosis].
Martínez-Valle F; Gironella-Mesa M; Solans-Laqué R
Med Clin (Barc); 2012 May; 138(15):667-72. PubMed ID: 22197598
[TBL] [Abstract][Full Text] [Related]
18. Infliximab in the treatment of amyloidosis secondary to Crohn's disease.
Cabezuelo JB; Egea JP; Ramos F; Torrella E; Muray S; Alcázar C
Nefrologia; 2012 May; 32(3):385-8. PubMed ID: 22592423
[TBL] [Abstract][Full Text] [Related]
19. Amyloidosis in juvenile chronic arthritis.
David J
Clin Exp Rheumatol; 1991; 9(1):73-8. PubMed ID: 2054972
[No Abstract] [Full Text] [Related]
20. The cutaneous amyloidoses. Pathogenesis and therapy.
Breathnach SM
Arch Dermatol; 1985 Apr; 121(4):470-5. PubMed ID: 3883907
[No Abstract] [Full Text] [Related]
[Next] [New Search]
